Abstract. In this paper, we report the development of micromachining techniques for a biodegradable polymer for the first time. By virtue of their ability to naturally degrade in tissues, biodegradable polymers hold immense promise as new materials for implantable biomedical microdevices. This work focuses on the establishment of microfabrication processes for biodegradable microstructures and microdevices. Three unique fabrication processes have been established: (1) a micro-molding process to form 3D microstructures in polycaprolactone (PCL) via a silicon micromachined mold, (2) a method of transferring metal patterns to surfaces of PCL substrates, (3) techniques for sealing both dry and liquid-filled PCL micro-cavities with a metal thin film (e.g. gold). The chemical compatibility of PCL with common micromachining chemicals have been investigated.
Introduction
Microdevices are being developed for biomedical applications such as implantable drug delivery systems [1] . However, the substrate materials of most existing microdevices are made from silicon, glass, silicone elastomer [2, 3] , or plastic materials [4] [5] [6] . Such devices would permanently remain in the biological tissue if not removed surgically. Because of the inherent difficulty associated with retrieving small-scale devices from tissues, it is advantageous to apply biodegradable polymers, such that the microdevices would naturally degrade and disappear in tissues over a desired period of time.
Synthetic and naturally-derived biodegradable polymers (BDP) [7] offer unique advantages for bio-implantable microsystems. Commonly used biodegradable materials along with their selected physical and chemical characteristics are listed in table 1. Poly(lactide-glycolide), for example, is used in drug delivery devices and sutures [8] . Polycaprolactone (PCL) is also used for drug delivery; drug compounds are mixed in the polymer matrix and gradually become released as the polymer is dissolved in the tissue [9, 10] . In the emerging field of tissue engineering, biodegradable polymers are used for realizing polymer scaffolds to assist tissue and cell growth during formation of artificial organs [7] . In such applications, biodegradable polymers have been shown to allow successful cell attachment, proliferation, and functioning.
The objective of this research work is to develop microfabrication methods of BDP, with one of the future applications being an actively controlled, bio-implantable drug delivery chip. Certain mechanical, thermal, and cellular response parameters were considered before PCL [11] was selected for our investigation among a number of candidate materials [7, 12] . PCL, an aliphatic polyester that has been intensively investigated as a biomedical material [9] , demonstrates a low melting point (57
• C) and a low glass-transition temperature (−62
• C). PCL can be degraded by micro-organisms as well as by a hydrolytic mechanism under physiological conditions [13] . Under certain circumstances, it is possible to enzymatically degrade crosslinked PCL (termed enzymatic surface erosion). Low molecular-weight fragments of PCL are also reportedly absorbed by macrophages intercellularly [14] . The PCL material has a significantly slower biodegradation rate than other BDP materials, making it suitable for design of longterm implantable systems such as Capronor, a US FDAapproved contraceptive device [9] . Another interesting property of PCL is its propensity to form compatible blends with a wide variety of polymers [15] . The toxicology of PCL has been extensively studied as part of the evaluation of Capronor [9] ; it is currently regarded as non-toxic and tissue compatible.
PCL is especially appealing for our current work as it also has the lowest unit price among all of the common BDP products off-the-shelf. Since our work focuses on the early investigation of the microfabrication process for a BDP, we choose the inexpensive material. It should be noted that 
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Chemical compatibility
Before the microfabrication processes for PCL were developed, the compatibility of PCL with common chemicals used in micromachining was investigated. Smooth, molded samples of PCL (5 × 5 × 2 mm 3 ) were immersed in approximately 200 ml of various liquid chemicals. Such chemicals include common etchants for organic materials (acetone and alcohol), for metals (gold and chromium etchants), for oxide (49% HF and buffered HF), and for photoresist (resist developers). After 30 min of exposure the PCL samples were removed and rinsed with de-ionized water. The samples were then examined to determine the extent of the chemical attack. First, a visual inspection under an optical microscope was performed to determine if there was any discoloration or surface erosion, then the surface profiles were examined using an AlphaStep surface profilometer to determine if any surface roughening occurred. Table  2 summarizes the chemicals tested and their compatibility, with all tests conducted at room temperature. Since we are focusing on short-term (e.g. 30 min) compatibility in the fabrication environment, long-term compatibility tests were not a focus in the current investigation.
Micro-molding
In silicon micromachining, anisotropic wet chemical etching is commonly used to produce three-dimensional (3D) features such as micro cavities. Such techniques, however, are not applicable for BDPs, which can be polycrystalline or even amorphous in nature. Since PCL, and most biodegradable materials, exhibit thermoplastic properties, micro-molding is a promising candidate for the low-cost, efficient fabrication of 3D microstructures in BDP substrates.
Micro-molding process was first used by other groups to form polymer microfabricated devices [3] . In this work, we investigated the micro-molding of BDPs. The new micromolding process to produce 3D microstructures in PCL is shown in figure 1 . PCL was re-flowed at above its melting temperature onto a mold ( figure 1(a) ) and detached after cooling and recrystallization ( figure 1(c) ). The 3D feature in the mold was precisely reproduced in the BDP substrate. SEM micrographs of the mold and resultant structures in PCL are shown in figures 2 and 3, respectively. There are two variations to the fundamental scheme. In both cases, the adhesion between the PCL and the mold is rather weak and the detachment process is readily achieved.
In the first method, a bulk-etched silicon mold was used. The mold contained the inverse of the desired microstructure in the PCL. A mesa, for example, can be formed by anisotropically etching {100} oriented silicon with ethylenediamine pyrocatechol (EDP) or KOH. Re-flowed PCL was molded from the silicon mesa at 100
• C in a convection oven for 5 min. The PCL piece cooled upon removal from the oven and detached from the silicon mold by itself due to buckling caused by the difference in the thermal expansion coefficients between the silicon and the PCL. It is also noteworthy that the molten PCL is prevented from overflowing by using elevated guard rings made of polydimethyl siloxane (PDMS). The degree of buckling is dependent on the size of the PCL piece. Typically the PCL pieces were approximately 1 cm × 1 cm in area. For such sizes, the buckling was rather small, although finite. We also found that the extent of buckling in the PCL can be alleviated by using low-temperature annealing, at a temperature below the melting point, but above room temperature. The curvature can be fully corrected while retaining the sharpness of the surface features. In the second variation, a PDMS mold was used instead of the silicon mold used in the previous case [2] . PDMS is a thermoset polymer. PCL microstructures were then made from this PDMS mold in the same manner as with the silicon mold. Unlike the silicon substrate, the flexible PDMS mold can be controllably peeled off due to the low adhesion energy of the PDMS to the PCL.
Transfer of patterned metal thin film
Deposition and patterning of metal film onto the BDP is the first step towards realizing a device with functionality. For the intended future application of drug delivery systems, for example, a thin metal film can be used to seal a cavity filled with drug solutions (see below). If a biocompatible gold thin film [16] is used, the seal cover can be dissolved anodically in physiological environments by applying a dc voltage (e.g. 1 V) between the sealing thin film and a reference potential [17] , thus releasing the liquid drugs embedded therein.
For semiconductor IC and MEMS processes, a metal film is thermally evaporated or sputtered using standard equipment onto the substrate surface. The wafer is spin coated with a layer of photoresist (PR), photolithographically patterned, and then the metal is selectively etched. However, our experiments showed that such a conventional process was not applicable to PCL fabrication. There were two major challenges: (1) we found that direct metal deposition on a PCL substrate worked poorly due to the low melting temperature of PCL. The high-temperature metal particles in thermal and e-beam evaporation systems tended to melt the surface layer of the PCL, resulting in surface roughening and deformation; (2) the iodine-based gold etchant attacked the PCL substrate. PCL is not allowed to contact the gold etchant directly.
A new fabrication technique was therefore developed, involving the transfer of a patterned metal thin film (e.g. gold) from a host silicon wafer to a PCL surface (figure 4). A silicon wafer was first prepared: a 10 µm thick layer of PR was spun onto silicon and completely exposed, followed by evaporation of a 4000 Å thick gold film and patterning of the resultant film. The wafer was then placed on a 57
• C hotplate A SEM micrograph showing a patterned gold thin film sealing a micro cavity in the substrate of the PCL substrate (corresponding to figure 6(c) ). The cavity is intentionally partially sealed to reveal the cross-section.
and the PCL was allowed to melt onto its front surface. The silicon-PCL assembly, cooled at room temperature, again detached as a result of the different expansion coefficients. We found that the metal film adheres much more strongly to the PCL. This property is discovered by experiments and the discovery is believed to be original. Once the BDP sample was lifted off the wafer, patches of PR may remain on the transferred gold film. The entire sample was then immersed in AZ photoresist developer to remove the residual PR. Note that a photoresist developer instead of acetone was used to remove the exposed photoresist as the developer does not attack the PCL. Figure 5 shows the transferred metal patterns (smooth lines) on the PCL surface.
The above-mentioned process is useful for transferring metal patterns onto solid PCL substrates without 3D microfeatures. The transfer of metal patterns onto the PCL with microcavities is achieved using the two derivative processes described in section 2.4. 
Seal of cavities
We first demonstrated the ability to seal dry (figure 6) microcavities with a gold thin film. A 5 µm thick photoresist was first spin coated onto the silicon wafer. The wafer was coated with 350 Å of sputtered chrome, followed by a 4000 Å layer of evaporated gold ( figure 6(a) ). The two metal depositions were conducted in two separate chambers, with the vacuum broken in between. Following metal deposition, the sample was diced into pieces (0.5-1 cm 2 ) and heated to 57
• C using a standard hot plate, at which point the PCL structure with microcavities contacted the silicon with proper alignment and contact pressure ( figure 6(b) ). Upon cooling, the sealed device was easily removed, utilizing the unique weak adhesion energy between the sputtered chrome and evaporated gold. The unique adhesion property was discovered by accident and used to its advantage in the current experiments. Figures 7 and 8 show a microcavity in PCL covered with a gold thin film; the coverage is partial to reveal the cross section. For the silicon handle wafer, the photoresist material can be easily removed by acetone such that the silicon wafer can be easily re-used.
The process to seal a liquid-filled cavity is shown in figure 9 . Liquid was first dispensed into microcavities ( figure 9(a) ). So far only de-ionized water has been sealed in the BDP cavities. Instead of pressing the PCL piece against the silicon piece (on the bottom), the PCL piece was on the bottom to prevent liquid spilling. The liquid inside microcavities did not affect the sealing process as the entire liquid drop resides below the level of the substrate front surface. A silicon piece with a patterned gold thin film was heated to 100
• C and immediately pressed against the PCL piece with proper alignment ( figure 9(b) ). The silicon piece was heated to a temperature above the melting temperature of the PCL because the temperature was expected to drop when the silicon piece was transferred from a stationary hotplate to the PCL. With the heat loss to the air is taken into account, the temperature of the silicon piece was greater than the melting temperature of the PCL when the silicon and the PCL pieces are contacted. The alignment is currently achieved by eye only, but can be easily improved using dedicated tools. In the future, the silicon piece can be constantly heated using a modified hand-held hot stage; in this case, the silicon piece needs only to be heated to 57
• C. The PCL piece and the silicon piece can be separated easily (figure 9(c)) due to the relatively weak adhesion between the gold and chromium layers. In future applications of drug delivery chips, the sealing film can be removed individually via anodic dissolution in the biological tissue.
Conclusions
Micromachining processes for a BDP have been developed and reported. Experiments show that PCL can withstand common micromachining chemicals including hydrofluoric acid, photoresist developer, and Cr etchant. Three novel processes have been demonstrated: a micro-molding process to realize 3D microscopic features of the BDP, PCL, a pattern transfer process to functionalize PCL with metal thin films, and a process to seal micromachined cavities. Future plans include investigating other BDPs and developing an active, controllable, drug-releasing chip.
